| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 66.68B | 78.89B | 62.74B | 58.56B | 52.98B | 51.62B |
| Gross Profit | 66.65B | 73.12B | 60.70B | 56.55B | 52.01B | 51.45B |
| EBITDA | 8.34B | 16.48B | 11.48B | 11.53B | 11.42B | 11.12B |
| Net Income | 6.29B | 9.08B | 5.75B | 5.65B | 5.90B | 5.59B |
Balance Sheet | ||||||
| Total Assets | 3.11T | 3.11T | 2.98T | 3.07T | 3.04T | 3.06T |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 161.55B | 171.57B | 341.75B | 598.66B | 770.55B |
| Total Debt | 18.82B | 15.75B | 19.54B | 82.95B | 104.86B | 585.72B |
| Total Liabilities | 2.97T | 2.96T | 2.84T | 2.92T | 2.90T | 2.93T |
| Stockholders Equity | 143.54B | 145.52B | 139.83B | 142.56B | 138.16B | 135.02B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -2.23B | 15.89B | 0.00 | -56.59B | 282.68B |
| Operating Cash Flow | 0.00 | 7.02B | 26.36B | 0.00 | -52.27B | 22.56B |
| Investing Cash Flow | 0.00 | -130.51B | -113.69B | -265.72B | -116.73B | -38.66B |
| Financing Cash Flow | 0.00 | 112.80B | -83.19B | 10.93B | -2.90B | 116.82B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥131.26B | 9.90 | ― | 2.71% | 21.01% | 42.25% | |
71 Outperform | ¥116.16B | 5.37 | ― | 3.05% | 49.84% | 156.03% | |
70 Outperform | ¥176.12B | 13.36 | 3.68% | 2.26% | 23.47% | 44.30% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | ¥174.83B | 10.12 | ― | 2.29% | 9.41% | 45.91% | |
65 Neutral | ¥87.68B | 9.19 | ― | 2.29% | 11.72% | 14.29% | |
64 Neutral | ¥110.42B | 23.87 | ― | 2.46% | 16.88% | 59.34% |